A detailed history of Bamco Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Bamco Inc holds 1,125,806 shares of VCYT stock, worth $40.5 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,125,806
Previous 1,125,806 -0.0%
Holding current value
$40.5 Million
Previous $24.4 Million 57.04%
% of portfolio
0.1%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$18.86 - $23.55 $188,600 - $235,500
10,000 Added 0.9%
1,125,806 $24.4 Million
Q1 2024

May 15, 2024

BUY
$21.0 - $29.1 $7.41 Million - $10.3 Million
353,000 Added 46.28%
1,115,806 $24.7 Million
Q4 2023

Feb 14, 2024

BUY
$19.72 - $28.68 $57,700 - $83,917
2,926 Added 0.39%
762,806 $21 Million
Q2 2023

Aug 14, 2023

BUY
$20.96 - $26.99 $821,066 - $1.06 Million
39,173 Added 5.44%
759,880 $19.4 Million
Q4 2022

Feb 14, 2023

SELL
$15.31 - $29.94 $858,891 - $1.68 Million
-56,100 Reduced 7.22%
720,707 $17.1 Million
Q2 2022

Aug 15, 2022

SELL
$15.45 - $29.52 $1.52 Million - $2.91 Million
-98,600 Reduced 11.26%
776,807 $15.5 Million
Q4 2021

Feb 14, 2022

SELL
$36.09 - $53.79 $2.28 Million - $3.39 Million
-63,067 Reduced 6.72%
875,407 $36.1 Million
Q3 2021

Nov 12, 2021

BUY
$35.62 - $52.97 $3.72 Million - $5.53 Million
104,384 Added 12.51%
938,474 $43.6 Million
Q2 2021

Aug 13, 2021

BUY
$32.94 - $56.62 $10.4 Million - $17.8 Million
314,900 Added 60.65%
834,090 $33.3 Million
Q1 2020

May 15, 2020

SELL
$16.13 - $30.17 $170,655 - $319,198
-10,580 Reduced 2.0%
519,190 $12.6 Million
Q4 2019

Feb 18, 2020

SELL
$20.78 - $29.99 $4.46 Million - $6.44 Million
-214,851 Reduced 28.85%
529,770 $14.8 Million
Q3 2019

Nov 14, 2019

BUY
$23.87 - $30.93 $1.75 Million - $2.27 Million
73,382 Added 10.93%
744,621 $17.9 Million
Q2 2019

Aug 15, 2019

BUY
$22.1 - $28.56 $14.8 Million - $19.2 Million
671,239 New
671,239 $19.1 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.57B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.